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Pseudomonas aeruginosa chronically infects the lungs of cystic ﬁbrosis (CF) patients. The
conditions in the CF lung appear to select for P. aeruginosa with advantageous pheno-
types for chronic infection. However, the mechanisms that allow the establishment of
this chronic infection have not been fully characterized. We have previously reported the
transcriptional analysis of two CF isolates strains 383 and 2192. Strain 2192 is a mucoid,
alginate overproducing strain whereas strain 383 is non-mucoid. Mucoid strains are asso-
ciated with chronic infection of the CF lung and non-mucoid strains are the typical initially
infecting isolates.To elucidate novel differences between these two strains, we employed
two methods of shotgun proteomics: isobaric tags for relative and absolute quantitation
(iTRAQ) and two-dimensional gel electrophoresis (2-DE). iTRAQ compares the amount of
protein between samples and relies on protein abundance, while 2-DE gel electrophoresis
depends on selection of separated protein spots. For both thesemethods, mass spectrom-
etry was then used to identify proteins differentially expressed between the two strains.
The compilation of these two proteomicmethods alongwithWestern blot analysis revealed
proteins of the HSI-I operon of the type 6 secretion system, showed increased expression
in 383 compared to 2192, conﬁrming the our previous transcriptional analysis. Proteomic
analysis of other proteins did not fully correlate with the transcriptome but other differen-
tially expressed proteins are discussed. Also, differences were noted between the results
obtained for the two proteomic techniques. These shotgun proteomic analyses identiﬁed
proteins that had been predicted only through gene identiﬁcation; we now refer to these as
“proteins of unknown functions” since their existence has now been established however
their functional characterization remains to be elucidated.
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INTRODUCTION
Pseudomonas aeruginosa is aGram-negative bacterium that is both
a ubiquitous environmental organism and an important oppor-
tunistic pathogen of humans. P. aeruginosa can cause infections
in compromised individuals such as those suffering from burns,
AIDS, patients undergoing treatment for cancer, or those with cys-
tic ﬁbrosis (CF). P. aeruginosa infection of the CF airway leads to
high mortality and morbidity.
The mucoid phenotype of P. aeruginosa is one of the most
extensively researched characteristics of this species (Govan and
Deretic, 1996; Ramsey and Wozniak, 2005). Mucoid strains over-
produce the exopolysaccharide called alginate (Figure 1). Alginate
is an unbranched linear polymer of partially acetylated β-d-
mannuronic acid and its C5 epimer α-l-guluronic acid. Alginate
synthesis begins in the cytoplasm and ends with secretion to the
extracellular milieu. The algD alginate biosynthetic operon (con-
taining algD844KEGXLIJFalgA; Chitnis and Ohman, 1993) and
gene algC (Zielinski et al., 1991) encode enzymes required for
synthesis of alginate. The biosynthetic genes are controlled by
the extracytoplasmic function alternative sigma factor σ22 (also
known as AlgT or AlgU), which is repressed by the transmem-
brane anti-sigma factor MucA (Martin et al., 1993). Mutation
of mucA causes unregulated σ22 to activate alginate production
(Martin et al., 1993). Recently, proteolytic degradation of MucA
has also been recognized as a mechanism for alginate production
(Qiu et al., 2008; Damron et al., 2009b; Wood and Ohman, 2009;
Damron and Yu, 2011). When σ22 is free and active, due to mucA
mutation or MucA proteolytic degradation, alginate overproduc-
tion will occur. In addition to increased expression of genes, σ22
is also known to repress gene expression as well (Wu et al., 2004;
Tart et al., 2005; Jones et al., 2010).
Ineffective clearance of P. aeruginosa in the environment in
the CF lung has been suggested to result in the conversion to
the mucoid, alginate over-expressing phenotype, which provides
these bacteria additional protection from antibiotics and phago-
cytic killing (Govan andDeretic, 1996; Lyczak et al., 2002).Mucoid
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FIGURE 1 | Phenotypes of P. aeruginosa CF isolates 383 and 2192 on
L agar media. Streaks of strains 383 and 2192 were cultured on L agar for
24 h at 37˚C. These two strains were isolated within 2 days apart from a
CF patient. Previous data indicated these strains are isogenic (Hanna et al.,
2000). The genome of strain 2192 has been sequenced1 (Mathee et al.,
2008).
variants of P. aeruginosa effectively establish themselves as dom-
inant pathogens in chronic lung diseases of CF patients (Lyczak
et al., 2002). However, many other factors in addition to alginate
overproduction have been described which contribute to the lung
infection of CF patients (Hogardt and Heesemann, 2010).
Transcriptome analysis of P. aeruginosa via microarray has
provided valuable insights into gene regulation of P. aeruginosa
on a global level (Goodman and Lory, 2004). In addition, mass
spectrometry provides proteomic analysis. In earlier studies with
P. aeruginosa, protein identiﬁcation has been performed using
a qualitative approach for the identiﬁcation of proteins by two-
dimensional gel electrophoresis (2-DE) followed by tandem mass
spectrometry (MS/MS) method (Quadroni et al., 1999; Malhotra
et al., 2000; Sherman et al., 2001; Nouwens et al., 2003; Arevalo-
Ferro et al., 2005; Sriramulu et al., 2005; Sharma et al., 2006).A sub-
proteomic approach has led to identiﬁcation and characterization
of the periplasmic, membrane, or secreted P. aeruginosa proteins
as potential virulence factors (Nouwens et al., 2003; Wehmhoner
et al., 2003; Blonder et al., 2004; Imperi et al., 2009). Recently,
P. aeruginosa gene products were identiﬁed by using collective data
from proteomic, transcriptional proﬁling, and signature-tagged
mutagenesis (Platt et al., 2008).Quantitative proteomics have been
developed using isotope labeling of peptides in a method known
as isobaric tags for relative and absolute quantitation (iTRAQ;
Lacerda et al., 2008). Most transcriptome and proteomic analy-
sis of P. aeruginosa have been performed on laboratory strains
(Firoved et al., 2002; Wood et al., 2006; Damron et al., 2009a)
along with a few studies with CF isolates (Hanna et al., 2000; Rau
et al., 2010).
Our laboratory has previously performed proteomic studies
of clinical isolates of P. aeruginosa strains 383 (non-mucoid)
1http://www.broad.mit.edu
and 2192 (mucoid; Figure 1), which were isolated from sputum
samples obtained from an individual with CF (Hanna et al., 2000).
Using PAO1 GeneChip arrays, we determined at least 188 genes
differ in expression between non-mucoid strain 383 and mucoid
strain 2192 (Rao et al., 2008). Since that time, the genome of 2192
has been sequenced2 (Mathee et al., 2008); pangenome analysis has
been performed and indicates niche adaptation is the force that
drives the composition of P. aeruginosa genomes (Mathee et al.,
2008).
Our hypothesis is that many other factors or systems, which
may contribute to the disease in CF are altered in expression
between mucoid and non-mucoid strains. In the present study,
we have taken a global approach to detect the novel differences
between the strains 383 and 2192 by using the shotgun proteomic
methods of both iTRAQ and 2-DE. Total whole cell proteins
were subjected to iTRAQ for quantiﬁcation. In addition, total
whole cell lysates and Triton X-114 soluble proteins were sepa-
rated by 2-DE gel electrophoresis. Our data are consistent with
the observations of an inverse relationship between the mucoid
phenotype and the type 6 secretion system (T6SS). This sug-
gests that the T6SS may be associated with non-mucoid infection
strains but repressed in mucoid infection strains. Furthermore,
iTRAQ and 2-DE proteomic analysis detected proteins that had
only been predicted by gene identiﬁcation of open reading frames
(ORF) with no known homologs. We now refer to these “hypo-
thetical” and “conserved hypothetical” proteins as “proteins of
unknown function” (PUF) and determined that some are differ-
entially expressed in the acute and chronic phenotypic strains of
P. aeruginosa.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
The bacterial strains used in this study, P. aeruginosa strains 383
and 2192, are non-mucoid and mucoid, respectively. These strains
were isolated 2 days apart from the sputum of the same CF patient
(Hanna et al., 2000). Bacterial cultures were grown overnight in
Luria Bertani (LB) medium at 37˚C in shaking (200 rpm), diluted
to 1:100 in 30ml of fresh media, and grown to mid-log phase, to
an optical density (OD600) of 0.5.
iTRAQ ANALYSIS
Total proteinswere extracted from strains 383 and 2192 usingTris–
EDTA buffer (10mM Tris; pH 8.3, 5mM EDTA). Brieﬂy, 10ml of
each bacterial culture of 0.5 (OD600) were harvested by centrifu-
gation and cell pellets were resuspended in 1.0ml of Tris–EDTA
buffer containing 50μl of cocktail protease inhibitors (Sigma-
Aldrich, St. Louis, MO, USA), and 1μl (5000 units) of benzonase
(Sigma). The cells were disrupted by sonication on ice four to
ﬁve times for 30 s with a micro-tip probe, then incubated at room
temperature for 1 h, followed by centrifugation at 6000× g for
15min at 4˚C. Supernatant solutionwas transferred to amicrofuge
tube and the protein concentration was estimated by Bradford
method using Bio-Rad protein assay reagent (Bio-Rad, Hercules,
CA, USA). Approximately 1mg of protein was precipitated with
2http://www.broad.mit.edu
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10% trichloroacetic acid (TCA) at 4˚C for 1 h and centrifuged at
20,800× g for 10min, followed by washing three times with cold
acetone. Analytical replicate samples from each strain were used
for iTRAQ labeling [Applied Biosystems Inc. (ABI), Foster City,
CA, USA].
One analytical separation was performed with replicate sam-
ples of each strain (383 and 2192). Samples were reduced, digested,
labeled, and combined per ABI’s standard protocol. Pooled sam-
ples were subjected to MS/MS for peptide/protein identiﬁcation
after strong cation exchange (SCX) chromatographic fractiona-
tion. iTRAQ reagents are isobaric in nature and thus yield similar
m/z for the same peptide for the ﬁrst stage of MS, when labeled
with either 114, 115, 116, or 117 tags. Brieﬂy, 100μg of proteins
from each strain were resuspended in dissolution buffer (0.5M
triethyl ammonium bicarbonate, TEAB), and then reduced, alky-
lated, digested, and labeled according to ABI’s standard protocol.
Brieﬂy, 20μl of dissolution buffer, 1μl of denaturing solution
(2% SDS), and 2μl of the reducing agent (Tris 2-carboxyethyl
phosphine) were added to each protein-containing tube and incu-
bated for 1 h at 60˚C. At the end of this reduction process, proteins
were brought to room temperature and the samples were alkylated
by addition of 1μl of cysteine blocking reagent [200mM methyl
methanethiosulfonate (MTT) in isopropanol] and incubation for
10min at room temperature. The reduced and alkylated protein
samples were digested with sequencing-grade modiﬁed porcine
trypsin that was reconstituted with Milli Q water; 5mg trypsin
was added to each tube and incubated overnight at 37˚C. The pep-
tide samples were labeled as follows: 383-A peptides were labeled
with 114, 2192-A with 115, 383-B with 116, and 2192-B with 117.
Each labeling was done in 70μl of ethanol at room tempera-
ture for 1 h (according tomanufacturer’s instructions). Equivalent
aliquots (77μg) of each labeled peptide solution were pooled in
a fresh tube and then dried completely in a vacuum centrifuge.
These pooled, tryptic-labeled peptide samples were desalted as per
manufacturer’s protocol prior to SCX chromatographic fraction-
ation. The entire sample was reconstituted in buffer A [10mM
KH2PO4, pH 2.93, 25% acetonitrile (ACN)] and loaded onto a
Pharmacia Mono S, 5mm× 50mm (Pharmacia, Uppsala, Swe-
den) column, and peptides were eluted with a linear gradient of
0–100% buffer B (10mM KH2PO4, pH 2.73, 25% ACN, and 1M
KCl) over 20min. For the MS/MS analysis, four fractions (8–11)
were selected based on the UV peptide elution proﬁle recorded
at absorbance of OD280, and dried samples were stored at −80˚C
(Figure S1 in Supplementary Material).
Each SCX fraction was reconstituted in loading buffer (98:2,
water/ACN, 0.1% acetic acid) and peptides were separated by
reverse phased chromatography. Two microliter of each fraction
were loaded onto an in-house LC column packed with 7.5 cm of
Gemini 5μmpackingmaterial; the columnwaswashed for 10min
with 1% acetic acid, and the sample was introduced into a QStar
mass spectrometer (ABI) via a Tempo nano-LC pumping system.
The LC gradient moved from 98% solvent A (0.1M acetic acid)
to 80% solvent B (a mixture of 90% ACN, 10% solvent A) over
120min, with a ﬂow rate of 250 nL/min. The QStar Elite was run
with 3300V electrospray voltage and a curtain gas setting of 17.
The scans were set to collect one MS scan followed by the product
ion scans of the three most intense ions from the MS scan.
During MS/MS analysis, peptides are fragmented with appro-
priate collision energy, and generate a product that corresponded
to reporter ions from 114, 115, 116, and 117m/z and peptide frag-
ment ions, from which amino acid sequences were deduced. This
MS/MS spectrum provides the data for protein identiﬁcation and
quantiﬁcation. The resulting data were analyzed using Protein-
Pilot software 4.0 (ABI) with the Paragon search engine to search
the Pseudomonas protein database of strain PAO13. The default
search settings used for quantitative processing and protein iden-
tiﬁcation allowed for trypsin cleavage sites lysine and arginine,
and the cysteine residues were blocked and alkylated with methyl
methanethiosulfonate as described in the iTRAQprotocol. Protein
detection threshold was set at 95% peptide conﬁdence level. All
four of the data ﬁles were concatenated into a single ﬁle for analy-
sis and quantitation. Peptide quantiﬁcation was carried out using
ProteinPilot, which computes the area under the peaks at 114, 115,
116, and 117Da, corresponding to the four iTRAQ reagents. The
ratio between proteins was calculated by using each dataset as a
denominator and shown in File S1 in Supplementary Material.
TOTAL PROTEIN EXTRACTIONS AND TRITON SAMPLE PREPARATIONS
FOR 2-DE GEL ELECTROPHORESIS
For 2-DE proteome analysis, total cellular proteins were extracted
from strains 383 and 2192 by using ChaotropicMembrane Extrac-
tionReagent 2 (Sigma; 5.0MUrea,2.0M thiourea 40mMTrizma™
base, 2.0%CHAPS, and 2.0%SB3-10,pH10.1), followed by reduc-
tion and alkylation procedures, as previously described (Herbert
et al., 1998; Molloy et al., 1998). Brieﬂy, 10ml of 0.5 (OD600) cul-
tures were harvested by centrifugation and cell pellets were resus-
pended in 2.0ml of Chaotropic Membrane Extraction Reagent
2 containing 100μl of protease inhibitors (Sigma), 1μl of ben-
zonase (Sigma), and 80μl of tributylphosphine (TBP; Sigma) to
get a ﬁnal concentration of 5mM in the total volume. Cell sus-
pensions were disrupted by sonication with a micro-tip probe
for 4–5min on ice, followed by centrifugation at 6000× g for
15min at 4˚C for supernatant collection, and removal of unbro-
ken cells. Further, the reduced proteins were alkylated by adding
23μl of iodoacetamide (Sigma) to a ﬁnal concentration of 15mM.
This mixture was incubated for 90min at room temperature in
the dark. Protein concentration was determined by the Brad-
ford method, and sample aliquots were stored at −20˚C until
use. Triton X-114 extractions were performed as described pre-
viously (Bordier, 1981), with slight modiﬁcations. Two ml bacte-
rial pellets from 0.5 OD600 cultures were collected from strains
383 and 2192. Proteins were extracted by solubilizing in 2ml of
1.7% Triton X-114 (Sigma) in 1× phosphate buffered saline (pH
7.4; PBS) with 100μl of protease inhibitors (Sigma) by gentle
rocking at 4˚C for 2 h. Insoluble cell debris was removed by cen-
trifugation at 6000× g for 15min at 4˚C and the Triton X-114
solubilized proteins were collected by transferring supernatants
to fresh microcentrifuge tubes, adding PBS to reduce the con-
centration of Triton X-114 to 1%, and incubating at 30˚C for
3min. The resulting cloudy solutions were partitioned into aque-
ous and detergent phases by centrifugation at 300× g for 3min
3http://www.pseudomonas.com
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at room temperature. The upper aqueous phase was transferred
to a fresh tube and re-extracted three times following the above
procedure. The lower partitioned detergent phase was pooled
from each extract and washed with cold 1× PBS. Finally, total
extract, aqueous partitioned, and detergent partitioned proteins
were precipitatedwith cold acetone (1:10, v/v) overnight at−70˚C.
Acetone precipitated proteins were collected after centrifugation at
20,800× g for 15min at 4˚C and protein samples were subjected
to 2-DE gel electrophoresis. The protein samples were prepared
for electrophoresis in Chaotropic Membrane Extraction Reagent
2 (Sigma) by reduction and alkylation procedures performed as
described earlier. Protein concentrations of each sample were
determined by the Bradford method and samples were stored at
−20˚C until use.
All protein preparations were subjected to 2-DE analysis by
using PROTEAN® IEF Cell (Bio-Rad). One hundred ﬁfty micro-
gram of proteins were solubilized in rehydration buffer (Bio-Rad)
containing 9M urea, 2% Triton X-100, 2% Pharmalyte pH 3–10
(Pharmacia), 2%β-mercaptoethanol,bromophenol blue, andTBP
(20mM) was added. Total proteins were applied on each immo-
bilized pH gradient (IPG) strip (isoelectric point [pI] of 3–10NL,
11 cm) from Bio-Rad, and active rehydration was carried out for
12–15 h under low-viscosity parafﬁn oil. Proteins were ﬁrst sepa-
rated by IEF with the following voltage/time proﬁle: a linear step
for 0–500V for 15min, 500–8000V up to a total of 30,000V/h.
After completing the isoelectrofocusing (IEF), strips were incu-
bated with equilibration buffer (3.7 g of Tris base, 150ml of 10%
SDS, 57.5ml of glycerol, 7.71 g of DTT and 0.2 g of bromophenol
blue, and made to 500ml distilled H2O) for 15–30min. For the
second dimension, proteins were resolved on 8–16% SDS-PAGE
(Criterion gels) with Dodeca cell system from Bio-Rad at 100V.
Gels were stained with silver or with Bio-Safe Coomassie (Bio-
Rad). Stained gels were scanned using HP scanner and images
were stored as tagged image ﬁles (TIFF) ﬁles. All the cored spots
from silver and Coomassie were characterized by either peptide
mass mapping (PMM) or tandem mass spectrometry (MS/MS)
for protein identiﬁcation.
PROTEIN IDENTIFICATION BY TANDEM MASS SPECTROMETRY
(MS/MS)
The selected individual protein spots were cut out of the stained
gels and were submitted to the W. M. Keck Biomedical Mass
Spectrometry Laboratory at the University of Virginia Biomedical
Research Facility for analysis, as described elsewhere (Hanna et al.,
2000). Data was analyzed by using the SEQUEST (ThermoFinni-
gan) search algorithm against Pseudomonas genome deposited
with National Center for Biotechnology Information (NCBI).
GENERATION OF T6SS ANTIBODIES
Rabbit polyclonal antibodies were raised and puriﬁed against
synthetic peptides CLASAPKPKDDEPQA for TssB1 (PA0083),
CVDGDPAHSTETTKA for TssC1 (PA0084), KYIDKSTPNLM-
MAC for Hcp1 (PA0085; GenScript, Piscataway, NJ, USA).
WESTERN BLOT ANALYSIS OF T6SS PROTEINS
Pseudomonas aeruginosa strains (383 and 2192) were grown on L
agar overnight at 37˚C. Cells were scraped of the plates and sus-
pended in L broth. Starting cultures were matched to an OD600
of 0.1 and then diluted 1:1 with L broth. Five milliliter of culture
were rotated at 100 rpm37˚C for 3 h until the strainswere atOD600
of 0.5. Cultures were streaked onto L agar to ensure non-mucoid
and mucoid phenotypes were maintained during log growth. Cell
suspensionswerematched anddiluted in 2×Laemmli buffer. Sam-
ples were frozen at −80˚C until separated on 12% polyacrylamide
SDS-PAGEand then transferred to 0.2μmnitrocellulose. Blocking
and probing of membranes were performed with 5% skim milk in
phosphate buffered saline. Polyclonal antibodies for T6SS proteins
were diluted 1:500 and monoclonal antibodies to RpoA (Neo-
clone). Secondary antibodies with horseradish peroxidase were
diluted 1:3000. AmershamAdvanced ECL chemiluminescent sub-
strate utilized for T6SS blots and Amersham ECL was used for
RpoA blots. Amersham ECL hyper ﬁlm was exposed for 1min to
probed membranes and developed.
RESULTS AND DISCUSSION
iTRAQ ANALYSIS OF THE PROTEOMES OF STRAINS 383 AND 2192
Early P. aeruginosa isolates taken from the CF airway are generally
non-mucoid and resemble environmental strains. Strains 383 and
2192 have been classiﬁed as isogenic (Hanna et al., 2000). Strain
383 is non-mucoid and thus represents an initially infecting isolate,
while 2192 is mucoid and represents a chronically infecting iso-
late. To discover the proteomic differences in these two CF isolates,
iTRAQ analysis and quantitation was performed. This approach is
a“gel-free”mass spectrometry technique that uses isobaric amine-
speciﬁc tags to compare the peptide intensities between samples
and infer quantitative values for corresponding proteins. Two ana-
lytical replicates of protein preparations from each strain were
subjected to digestion and iTRAQ labeling, followed by MS/MS
analyses. Expression data were compiled by scoring of peptides
with 99% conﬁdence using ProteinPilot software version 4. Pro-
teins were identiﬁed on the basis of having at least one distinct
peptide with threshold of 1% false positive rate using the Protein-
Pilot search algorithm against all bacterial and non-redundant
database entries deposited with NCBI. In this study we report the
identiﬁcation of 399 proteins (above 95% conﬁdence) from 5690
peptides. The relative quantiﬁcation data were obtained for 297
proteins between strains 383 and 2192. Of the quantiﬁed 297, 81
proteins showed signiﬁcant p values in either one or both iTRAQ
replicates (File S1 in Supplementary Material). In comparison
with earlier studies of other P. aeruginosa strains (Guina et al.,
2003; Wu et al., 2005), here we have observed similar numbers
differentially expressed proteins.
Isobaric tags for relative and absolute quantitation analysis
of the proteomes of 383 and 2192 identiﬁed 297 proteins dif-
ferentially regulated (Table S1A and File S1 in Supplementary
Material). The 297 quantiﬁed proteins can be grouped into three
categories: (1) 67 proteins (23%) showed higher expression in
the non-mucoid strain, 383, (2) 77 proteins (26%) in showed
higher expression in the mucoid strain, 2192, and (3) 153 pro-
teins (51%) showed no difference in relative expression between
the non-mucoid andmucoid strains (Table S1A in Supplementary
Material).
Bioinformatics analysis of the 297 proteins recognized from
iTRAQ analysis allowed functional classiﬁcations as deﬁned by the
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Pseudomonas GenomeDatabase4 (Winsor et al., 2009; Table 1 and
File S2 in Supplementary Material). The distribution of proteins
observed showed representatives of almost all of the functional
classes identiﬁed suggest iTRAQ analysis. However, this may rep-
resent a shallow sampling of the proteome andmay also deﬁne the
limits of detection. No proteins corresponding to the functional
classes of antibiotic resistance and susceptibility, chemotaxis, or
phage proteins were detected in the analysis, but proteins assigned
to the other 23 functional classes were identiﬁed. Proteins repre-
senting 16% the amino acid biosynthesis and metabolism class
were observed. Interestingly most of the proteins of this class
were expressed at equal levels between the two strains. We would
expect that a mucoid P. aeruginosa strain, such as 2192 would
have increased expression of proteins corresponding to the cell
wall/LPS/capsule class. iTRAQ analysis indicated four proteins of
this class were upregulated in strain 2192 (Table 1). Furthermore
the mucoid phenotype would place a demand on metabolism
pathways to overproduce alginate. Eight proteins of the central
intermediary metabolism class were upregulated in mucoid strain
2192 (Table 1). However, the protein class of energy metabolism
4www.pseudomonas.com
has an equal number of increased and decreased proteins and 13
proteins equally expressed. If iTRAQ analysis properly represents
the proteome, it would be expected that some classes of proteins
would not be discordant. Seven proteins of the associated with
DNA maintenance were equal expressed between the two strains
(Table 1).
The bacterial membrane is the largest single structure of a bac-
terium. Moreover, homeostasis is maintained by upholding the
integrity of this structure. In our iTRAQ analysis of the two CF
isolates, we noted a total of 12 proteins (19.4% of the entire class),
which correspond to the fatty acid and phospholipid metabolism
class (Table 1). Since membrane integrity is paramount for bac-
teria, we would predict this class would be highly represented
in a distribution of the total proteome. Another validation of
the iTRAQ analysis was the identiﬁcation of differential expres-
sion of transcriptional regulators and transcriptional machinery
(Table 1). Transcriptional regulators are rarely expressed at high
levels. Therefore, identiﬁcation of these regulators via iTRAQ
suggests the analysis was able to detect at least some proteins
that may be of relatively low abundance. Conversely translational
machinery would likely represent a high amount of the pep-
tide concentration within a total protein lysate. iTRAQ analysis
Table 1 | Distribution and PseudoCAP functional classification of proteins identified in CF strains 383 and 2192 by iTRAQ analysis.
PseudoCAP functional class (total no. in class) 2192/383 iTRAQ expression Total
proteins
identified
Percentage
of functional
class
Increased
expression
Decreased
expression
Equal
expression
Adaptation and protection (179) 1 0 6 7 3.9
Amino acid biosynthesis and metabolism (242) 10 9 20 39 16.1
Antibiotic resistance and susceptibility (55) 0 0 0 0 0
Biosynthesis of cofactors (160) 1 2 6 9 5.6
Carbon compound catabolism (172) 1 1 4 6 3.5
Cell division (29) 3 0 1 4 13.8
Cell wall/LPS/capsule (182) 4 0 2 6 3.3
Central intermediary metabolism (99) 8 0 7 15 15.2
Chaperones and heat shock proteins (56) 3 2 2 7 12.5
Chemotaxis (64) 0 0 0 0 0
DNA replication, recombination, modiﬁcation, and repair (88) 2 1 7 10 11.4
Energy metabolism (208) 3 3 13 19 9.1
Fatty acid and phospholipid metabolism (62) 3 4 5 12 19.4
Hypothetical, unclassiﬁed, unknown (2002) 16 7 9 32 1.6
Membrane proteins (676) 2 4 2 8 1.2
Nucleotide biosynthesis and metabolism (87) 2 1 7 10 11.5
Protein secretion/export apparatus (124) 0 2 3 5 4.0
Putative enzymes (474) 2 1 1 4 0.8
Related to phage, transposon, or plasmid (65) 0 0 0 0 0
Secreted factors: toxins, enzymes, alginate (105) 2 1 0 3 2.9
Transcription, RNA processing, and degradation (55) 1 6 6 13 23.6
Transcriptional regulators (478) 3 0 5 8 1.7
Translation, post-translational modiﬁcation, degradation (197) 8 17 46 71 36.0
Transport of small molecules (587) 0 3 5 8 1.3
Two-component regulatory systems (121) 0 0 1 1 0.8
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identiﬁed 36% of the PseudoCAP functional class of transla-
tion, post-translational modiﬁcation and degradation. Seventy-
one of the 197 proteins belonging to this class were identiﬁed.
However, most (46) were equally expressed by the two strains
(Table 1).
We have also compared the proteins detected by iTRAQ with
the location of the genes on the chromosome. As anticipated by
our microarray analysis (Rao et al., 2008), in some cases proteins
expression seemed to correspond to genes organized in operons.
A particularly prominent region of the chromosome from PA4239
to PA4274, which encodes most of the 50S and 30S ribosomal
subunits, were identiﬁed in our iTRAQ analysis (Table S1B in
Supplementary Material). In vitro growth analysis, as determined
by ribosomal content, has previously suggested that P. aeruginosa
isolated from chronically infected patients grow as much as three-
fold slower than laboratory strains such as PAO1 (Yang et al., 2008).
Here in our iTRAQ analysis, we observed similar down-regulation
of ribosomal proteins in strain 2192 (Table S1A in Supplementary
Material).
The high detection of ribosomal proteins in both samples likely
decreases the depth of detection of the total proteome and is a lim-
itation of the current study. In light of this, one way to increase the
depth of iTRAQ analysis may be to deplete the amount of trans-
lation associated proteins in a sample. Fractionations that remove
the translational machinery may result in more unique analysis of
a proteome. This idea is reminiscent of the recent push to deplete
rRNA from total RNA samples for RNA-seq analysis. With the
majority of a total RNA sample being comprised of rRNA, removal
of rRNA can provide more unique sequence analysis. Application
of ribosomal depletion to total protein samples may increase the
depth of analysis of a proteome and is currently being investigated
in our laboratory.
Table 2 indicates selected proteins identiﬁed in iTRAQ analy-
sis. Additional data representing the entire iTRAQ analysis is
supplied in Files S1 and S2 in Supplementary Material. Since
strain 2192 is mucoid, we would expect to see proteins such as
those that play a role in alginate overproduction. Our proteomic
analysis indicated that alginate motility regulator Z (AmrZ),
AlgF, AlgC, and AlgD were upregulated in mucoid strain 2192
(Table 2). AmrZ, is a ribbon–helix–helix DNA-binding protein
(Baynham et al., 2006) that can act as a transcriptional repres-
sor (Tart et al., 2006) or enhancer of algD expression (Baynham
et al., 1999). It was expected that AmrZ would be present as
we had also observed its increased expression in our previous
transcriptome analysis (Rao et al., 2008). AlgC is a phospho-
mannomutase enzyme which catalyzes the second step in the
alginate pathway (Zielinski et al., 1991). AlgC converts mannose
6-phosphate into mannose 1-phosphate. Furthermore, AlgC is
a phosphoglucomutase involved in LPS synthesis (Coyne et al.,
1994). Here we observed AlgC signiﬁcantly upregulated in strain
2192 (Table 2). AlgD, GDP-mannose 6-dehydrogenase, converts
GDP-mannose into GDP-mannuronate which is the precursor
of polymannuronic acid (Tatnell et al., 1994). Another alginate
enzyme, AlgF was also upregulated by not identiﬁed as signiﬁcant
due to low number of peptide identiﬁcations (Table 2). AlgF is
one of three proteins that function to acetylate O-2 and or O-3
of the mannuronic acid residues (Franklin and Ohman, 2002).
Acetylation changes the physical and immunological properties of
the alginate (Pier et al., 2001).
In addition to identifying σ22-dependent alginate produc-
tion proteins, outer-membrane protein F (PA1777) was also
upregulated in strain 2192 (Table 2). Previous studies have shown
that OprF is upregulated in mucoid strains (Hanna et al., 2000;
Malhotra et al., 2000) and is directly controlled by σ22 (Firoved
et al., 2002). Thus, our shotgun proteomic analysis was validated
by the identiﬁcation of some known alginate biosynthesis proteins
and AlgU-dependent proteins such as OprF that were upregulated
in the mucoid 2192 strain.
When P. aeruginosa overproduces alginate, there would be high
demands on the central metabolism to produce metabolic inter-
mediates and such to fuel the high energy demand for alginate
overproduction. In Table 2, a number of proteins are shown that
have direct roles in metabolism. Additionally, we noticed a num-
ber of hypothetical proteins upregulated in 2192 some of which
are shown in Table 2.
Several heat shock proteins were downregulated in strain 2192
(Table 2). GroES, HtpG, and GroEL were signiﬁcantly down-
regulated. Previous work has shown that CF patients produce
antibodies to GroEL (Ulanova et al., 1997). Other recent work
has shown that heat shock proteins such as GroES and HtpG are
actually downregulated in bioﬁlms (Patrauchan et al., 2007). It is
interesting that heat shock proteinsmay be differentially expressed
depending on the growth conditions such as planktonic versus
bioﬁlm modes of growth.
Many total transcriptome analyses have examined the effect
of σ22 expression (Firoved et al., 2002, 2004a,1991; Firoved and
Deretic, 2003; Wood et al., 2006; Wood and Ohman, 2009). How-
ever, here unlike other studies, we were also interested in proteins
that have decreased expression in mucoid strains. In our iTRAQ
analysis, three proteins which are components of one (HIS-I) of
the three T6SS (Mougous et al., 2006) were downregulated in the
mucoid strain. These proteins, TssB1 (PA0083), TssC1 (PA0084),
Hcp1 (PA0085), have greater expression levels in non-mucoid
strain 383 than in mucoid strain 2192 (Table 2). Hcp1 is secreted
by the T6SS and has been found in CF sputum (Mougous et al.,
2006). CF patients also have antibodies in their serum to Hcp1
(Mougous et al., 2006). Although the exact role of Hcp1 is not
clear, it has been suggested that Hcp1may form a channel through
which macromolecules might pass and may be used for commu-
nication with the host (Mougous et al., 2006). Recently, the HSI-I
system was shown to secrete Tse2 (PA2702) which is a toxin that
arrests both prokaryotes and eukaryotes; however, Tse2 is targeted
toward prokaryotes (Hood et al., 2010).We do not observe expres-
sion of Tse2 in either of our proteomic analysis or differential
expression in transcriptomic analysis (Rao et al., 2008); however,
tse2 is present in the 2192 genome5.
RetS is a hybrid sensor kinase that controls expression of the
T6SS in P. aeruginosa. Without the retS, all of the HSI-I genes
are highly expressed (Goodman et al., 2004; Mougous et al., 2006;
Ventre et al., 2006; Figure 2). Comparison of our previous tran-
scriptome analysis to the transcriptome analysis ofretS is shown
5http://www.broad.mit.edu
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Table 2 | Selected proteins with differential expression between strains 383 and 2192 as observed by iTRAQ analysis.
Na PA loci Name Peptidesb 2192-A/383-A 2192-B/383-B Average ABc
115:114 pValue 115:114 117:116 pValue 117:116
285 PA3902 Hypothetical protein 1 6.75 0.0983 24.47 15.61
305 PA3819 Hypothetical protein 1 18.87 0.0927 9.32 14.09
283 PA3550 Alginate o-acetyltransferase AlgF 1 6.31 17.41 11.86
221 PA0315 Hypothetical protein 2 8.40 4.85 6.63
317 PA3031 Hypothetical protein 1 5.52 7.29 6.41
110 PA3385 Alginate and motility regulator AmrZ 5 9.90 0.0001 6.08 0.0066 7.99
32 PA3540 GDP-mannose 6-dehydrogenase AlgD 9 4.26 0.0003 7.27 0.0001 5.76
54 PA5322 Phosphomannomutase AlgC 7 5.91 0.0020 5.54 3.09E-05 5.73
134 PA3755 Ecotin precursor Eco 4 3.19 0.0409 2.75 0.0047 2.97
132 PA5060 Polyhydroxyalkanoate synthesis protein PhaF 4 3.07 0.0085 2.83 0.0017 2.95
164 PA1155 Ribonucleoside reductase, small chain NrdB 3 2.70 0.0014 1.52 0.0347 2.11
215 PA4922 Azurin precursor Azu 2 2.33 0.0096 1.79 0.0227 2.06
194 PA3471 Probable malic enzyme 2 2.22 0.0447 1.51 0.1020 1.87
34 PA0555 Fructose-1,6-bisphosphate aldolase Fda 9 1.89 0.0115 1.73 0.0004 1.81
88 PA0552 Phosphoglycerate kinase Pgk 5 1.74 0.0555 1.83 0.0016 1.78
119 PA3040 Probable DNA-binding protein 5 1.90 0.0051 1.47 0.0000 1.68
61 PA0962 Probable DNA-binding stress protein 8 1.56 0.0562 1.40 0.0018 1.48
128 PA1777 Outer-membrane protein OprF precursor 4 1.61 0.0397 1.34 0.0184 1.47
78 PA0625 Succinate-semialdehyde dehydrogenase GabD 6 1.62 0.0533 1.32 0.0347 1.47
44 PA3001 Probable glyceraldehyde-3-phosphate dehydro-
genase
9 1.29 0.0247 1.55 0.0004 1.42
70 PA1165 Ribonucleoside reductase, large chain NrdA 7 0.96 0.6108 1.73 0.0010 1.35
18 PA1588 Succinyl-CoA synthetase beta chain SucC 12 1.27 0.0396 1.34 0.0067 1.30
20 PA2950 Hypothetical protein 12 1.12 0.2466 1.40 0.0001 1.26
45 PA4386 GroES protein 11 0.98 0.8852 0.84 0.0355 0.91
91 PA1586 Dihydrolipoamide succinyltransferase SucB 6 1.00 0.9967 0.77 0.0230 0.88
120 PA4315 Transcriptional regulator MvaT, P16 subunit 5 1.00 0.9881 0.70 0.0003 0.85
11 PA1596 Heat shock protein HtpG 20 0.84 0.0727 0.82 0.0056 0.83
142 PA4232 Single-stranded DNA-binding protein 4 0.65 0.0185 1.01 0.9193 0.83
273 PA5253 Regulatory protein AlgP 1 0.86 0.7890 0.66 0.1443 0.76
47 PA5016 Dihydrolipoamide acetyltransferase AceF 8 0.75 0.0127 0.80 0.0273 0.77
2 PA4385 GroEL protein 49 0.75 0.0000 0.69 0.0000 0.72
181 PA2853 Outer-membrane lipoprotein OprI precursor 3 0.69 0.1906 0.69 0.0376 0.69
38 PA1587 Lipoamide dehydrogenase-glc 8 0.46 0.0130 0.85 0.1952 0.66
206 PA3836 Hypothetical protein 2 0.65 0.1557 0.52 0.0231 0.59
58 PA1092 Flagellin type B FliC 7 0.48 0.0275 0.68 0.0110 0.58
103 PA0085 T6SS protein Hcp1 4 0.31 0.0008 0.30 0.0002 0.30
244 PA0083 T6SS protein TssB1 2 0.54 0.2784 0.39 0.2798 0.46
248 PA0084 T6SS protein TssC1 2 0.42 0.61 0.1531 0.51
aThis column indicates the protein number which corresponds to the raw iTRAQ File S1 in Supplementary Material.
bThis column indicates the number of peptides at 95% conﬁdence.
cThis column indicates the average of the two replicates. Proteins that show at least one replicate with a signiﬁcant p value (less than 0.05) are colored red if the
protein was upregulated or green if the protein was downregulated.
in Figure 2. It seems than non-mucoid strain 383 has increased
expression of most of the HIS-I operon and the HSI-II genes
hsiA2, hsiC2, and hsiF1 (Figure 2). Furthermore, as mentioned,
T6SS proteins TssB1, TssC1, Hcp1 were detected in iTRAQ analy-
sis (Table 2). Also of interest, HSI-II genes were not affected by
deletion of retS, but strain 383 has increased HSI-II expression
of hsiA2, hsiC2, and hsiF2 (Figure 2). These data suggest that
mucoidy may suppress expression of Type 6 secretion machinery
in P. aeruginosa. To further corroborate this, examination of the
literature revealed that inactivation of σ22 in amucA mutant strain
caused increased expression of HSI-I and HSI-II genes (Tart et al.,
2005). In a recent study, extensive transcriptome analysis of early
and lateCF isolates revealed that, tssB1, tssC1, and hcp1were upreg-
ulated in non-mucoid derivatives of mucoid CF strains (Rau et al.,
2010). Collectively, our data alongwith others suggested an inverse
relationship between the T6SS and the mucoid phenotype of
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FIGURE 2 |Type 6 secretion operons and their expression in strain 383
and 2192.The relative expression of the type 6 secretion system (T6SS)
genes are indicated for the comparisons of strain 383 to 2192 from Rao
et al. (2008) and also the relative expression from a retS deletion mutant
whereT6SS genes are uniformly upregulated (Goodman et al., 2004;
Mougous et al., 2006; Ventre et al., 2006). Genes are named and colored
according to Pseudomonas Genome Database. (A,B) Indicates the P.
aeruginosa HSI-I and HSI-II operons of T6SS genes, respectively.
P. aeruginosa. It has been previously theorized that the T6SS may
be used to out compete other bacteria and increase the ﬁtness of
P. aeruginosa for infection of the CF lung (Hood et al., 2010).
The addition of mucoid phenotype to this model paints a pic-
ture whereby early non-mucoid isolates compete to initiate infec-
tion and then mucoid phenotype emerges, after which chronic
infection can be established, negating the necessity of T6SS.
2-DE ELECTROPHORESIS WITH MS DETECTION OF TOTAL PROTEIN
SAMPLES FROM STRAINS 383 AND 2192
One inherent drawback to the use of chromatography-based pro-
teomics is potential bias due to association and elution of peptides
during liquid separation. Theoretically, some peptides could lost
due to interactions during separation. The advantage of 2-DE
analysis is that it gives the size and pI of the isolated proteins,
whereas only protein fragments are detected by iTRAQ. To visu-
alize protein differences between the non-mucoid strain 383 and
the mucoid strain 2192, independent biological samples for each
strain, 383 and 2192, were separated and representative examples
are shown in Figure S2 in Supplementary Material. Spots with
differential expression were visualized (Figure S3 in Supplemen-
tary Material) and quantiﬁed for each strain. The predicted size
and pI were compared to that of the full-length protein sequences
(Table S2A in Supplementary Material). A protein spot on 2-DE
can contain multiple co-migrating proteins (Table S2A in Sup-
plementary Material). To determine the proteins that make up a
2-DE spot, either PMMormass spectral analysis or both were per-
formed (Table S2A in Supplementary Material). PMM indicates
the proteins that are themost abundant in a cored spot (Table S2B
in Supplementary Material). MS/MS does not suggest a protein
is the most abundant but rather identiﬁes peptides that may cor-
respond to the any protein in the cored spot. As expected half of
the protein spots analyzed contained multiple proteins and some
proteins were identiﬁed in more than one location (Table S2A in
Supplementary Material).
Total protein lysates, as well as membrane, and extracellular
protein enriched preparations, were utilized for 2-DE analysis. For
membrane/extracellular preparations, Triton X-114 treatments as
indicated in Section “Materials and Methods”were also employed
to enrich for detergent-soluble hydrophobic membrane proteins
FIGURE 3 |Two-dimensional gel protein analysis of strains 383 and
2192. (A) Indicates outer-membrane proteins that were analyzed and (B)
indicates other proteins of interest. Samples are designated as follows:
whole cell total soluble extract, total Triton X-114 soluble extract, aqueous
phase extract and detergent phase extract. Approximately 15μg of total
protein was focused in a 3–10 (NL) IPG strips using a PROTEAN IEF cell
(Bio-Rad). Second dimension, focused IPG strips were placed onto 8–16%
SDS-PAGE Criterion gel and proteins were separated by molecular size.
Following electrophoresis gels were silver stained and stored in distilled
water with 0.5% acetic acid. Closed red circles represent cored spots with
the core numbers indicated whereas dashed red circles indicate the
location of spots for comparison that were not cored or MS identiﬁed.
Closed and dashed red circles are indicated smaller on PA0315 panels to
indicate the protein spot precisely due to a closely co-migrating spot. All
cored protein spots indicated were the most abundant protein in the
sample as determined by peptide mass mapping (Table S2 in
Supplementary Material) except spot 43, which corresponds to PA0315.
(Bordier, 1981). This method has been used in other bacterial
proteomic studies (Sinha et al., 2005). 2-DE analysis revealed
two outer-membrane proteins,OprH andOprFwere differentially
expressed between strains 383 and 2192 (Figure 3A). OprH and
OprF spotswere visible in theTritonX-114 enrichment as expected
(Figure 3A). Previously, it has been shown that OprH protein is
expressed in both mucoid and non-mucoid strains (Kelly et al.,
1990; Hanna et al., 2000). Here, an OprH protein spot was
observed in both strains but was visually more abundant in the
mucoid 2192 strain than non-mucoid strain 383 (Figure 3A)
however our densitometry did not corroborate this observation
(Table 3).
One differential stained protein spot between mucoid strain
2192 and non-mucoid strain 383 (whole cell extract spot #39 and
#53 Triton X-114 preparation) was a conserved hypothetical pro-
tein (PA0460; Figure 3B). Little to no information is available for
PA0460 except that it has been shown to be ﬁve-fold upregulated
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when the sensor kinase phoQ is deleted from strain PAO1 (Good-
erham et al., 2009). Based on our data presented here (Figure 3B),
PA0460 may be a secreted protein, as it was predicted with signal
peptide at N-terminal 21 amino acids followed by a cleavage site
(data not shown). Spot #43 from mucoid strain (2192) whole cell
extract identiﬁed PA0315, another conserved hypothetical protein
(Figure 3B). PA0315 was upregulated in 2192 and our densitome-
try corroborated this observation. Recent data suggests PA0315
may be a homolog to a quorum sensing regulated protein of
Burkholderia cepacia (Riedel et al., 2003).
TYPE 6 SECRETION PROTEIN EXPRESSION IN STRAINS 383 AND 2192
Our previous transcriptome analysis had indicated a differen-
tial expression of T6SS proteins as described above. Furthermore,
iTRAQ analysis revealed a signiﬁcant decrease in Hcp1 in strain
2192. As expected, 2-DE gel electrophoresis conﬁrmed our iTRAQ
analysis (Table 2) that Hcp1 and TssB1 (PA0083) were increased
in expression in 383 (Figure 3B and Table 3). However, more
direct conﬁrmation of this observation was necessary. For this,
antibodies speciﬁc to TssB1 (PA0083), TssC1 (PA0084), and Hcp1
(PA0085) were used to quantify expression of the T6SS in CF
strains 383 and 2192. In Figure 4, Western blot analysis is shown
for TssB1, TssC1, and Hcp1. Antibodies speciﬁc for the alpha sub-
unit of RNA polymerase (RpoA) were utilized as a loading control
for the analysis.Western blot analysis conﬁrmed iTRAQ and 2-DE
and showed that TssB1 and Hcp1 were more highly expressed in
the non-mucoid strain 383 thanmucoid strain 2192 (Figure 4). Of
interest antibodies for TssC1 (PA0084) suggested that TssC1 cor-
relates with TssB1 and Hcp1 expression. These data suggest that
strain 383 has increased T6SS protein expression than strain 2192
(Figure 4). Ultimately our data corroborate both the microarray
and the two shotgun proteomic methods and show that the T6SS
is differentially regulated in CF strains 383 and 2192.
CONCLUSION AND FUTURE DIRECTIONS
The goal of this study was to obtain the proteomic proﬁles of
P. aeruginosa non-mucoid strain 383 and mucoid strain 2192 to
discover novel differences. To achieve this goal, we utilized a two
different complementary proteomic techniques (iTRAQ and 2-
DE) followed by MS analysis and correlated these results with
our previous transcriptome analysis (Rao et al., 2008). Microarray
analysis elucidates the relative gene expression proﬁles between
RNA samples; proteomic approaches such as iTRAQ and 2-
DE/MS can validate microarray analysis and provide insightful
information. As we expected these techniques identiﬁed proteins
differentially regulated between strains 383 and 2192. However,we
have also noted some limitations of these proteomic approaches.
FIGURE 4 |Western blot analysis ofType 6 secretion system (T6SS)
proteins in strains 383 and 2192. L broth cultures were inoculated with
the strains 383 and 2192 and grow at 37˚C into log phase (OD600 O.5). Log
phase whole cells suspended in L broth were added to equal volumes of
2× Laemmli buffer and subjected to separation by 12% SDS-PAGE and
electro-transferred to 0.2μm nitrocellulose membranes. Membranes were
probed with the antibodies indicated. Molecular weight markers are
indicated showing the relative migration of proteins detected. Shown is a
representative of three independent experiments.
Table 3 | Selected proteins quantified from cored protein spots of 2-DE.
PA no. Protein 2-DE spot no. Fold increase 383/2192 2-DEa,b Fold increase 383/2192 iTRAQa,c
PA0083 TssB1 28 4.06 2.2 (NS)
PA0085 Hcp1 35 1.14 3.3
PA0315 Hypothetical protein 43 NDe 0.61 (NS)
PA0460 Hypothetical protein 53 NDd NI
PA1159 Cold-shock protein 46 1.1 1.1
PA1178 Outer-membrane H1 29 2.46 NI
PA1777 OprF 55 ND 0.7
aAll the values are represented in log 2 scale and additional data can be found in (Table S2 in Supplementary Material).
bND indicates that protein spot intensity was not measured in 2-DE gels.
cNS indicates not signiﬁcant by iTRAQ analysis or NI indicates not identiﬁed.
dPA0460 fold increase is not indicated because PMM was not performed on spot 39, which contains other proteins (Table S2A in Supplementary Material).
ePA0315 fold increase is not indicated because PMM was not performed on spot 43, which contains other proteins (Table S2A in Supplementary Material).
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For example, proteomic techniques such as iTRAQ and 2-DE
currently do not give a complete protein proﬁle. Our iTRAQ pro-
teomic analysis gave expression data for only 4.8% of the ORF of
strain 2192 consistent with other studies. In spite of this limita-
tion, we were able to identify novel biological differences between
isolates of P. aeruginosa from a single CF patient. iTRAQ and 2-
DE analysis revealed a differential expression of the T6SS in strains
383 and 2192. In non-mucoid strain 383, proteins TssB1 andHcp1
were observed with increased spot intensities. iTRAQ quantiﬁca-
tion data also indicated an increase in TssB1 and Hcp1. iTRAQ
and 2-DE results were corroborated byWestern blot analysis using
T6SS antibodies for TssB1, TssC1, Hcp1 (Figure 4). Most of T6SS
analysis has been performed with laboratory strains. Our data
suggest 383 and 2192 may be useful prototype strains to further
elucidate T6SS. Collectively, our data indicates an inverse relation-
ship between the T6SS and the chronic mucoid phenotype which
is controlled by σ22.
Previously, among the 99 proteins that we identiﬁed in our
proteomic analysis of PAO1, 9% were “hypothetical” and 6%
were “conserved hypothetical” (Sherman et al., 2001). Further-
more, the P. aeruginosa pangenome (Mathee et al., 2008) and
recent genome sequencing efforts indicate there are many ORF
left to be characterized. Here among the proteins identiﬁed
at least 25% were “hypothetical” or “conserved hypothetical”.
We now refer to these as PUFs; since they have been con-
ﬁrmed by mass spectral analysis, the existence of these pro-
teins are no longer hypothetical. This intermediate classiﬁca-
tion between hypothetical and characterized protein is impor-
tant because it conﬁrms the annotation of an organism. The
P. aeruginosa reference strain, PAO1, currently contains 2002
hypothetical ORF. It is likely many of these proteins have been
identiﬁed by proteomic approaches by various studies (66 were
identiﬁed here) but searching the literature for each hypothet-
ical can be difﬁcult given the body of data in the public
domain. We believe that one potential way to facilitate the elu-
cidation of PUFs into characterized proteins is to begin database
compilation of the PUFs and the studies in which they were
identiﬁed.
In conclusion, iTRAQ, 2-DE, and Western blot analyses indi-
cated differential expression of many proteins between these two
CF isolates. Multiple approaches directed focus on a differential
regulation of T6SS proteins between the non-mucoid strain 383
and the mucoid strain 2192. We recognized that one limitation
of this approach was the use of standard laboratory growth con-
ditions. Future studies could utilize synthetic growth media that
better mimic CF conditions.
Our study suggests that iTRAQ analysis provides insightful
proteomic data, but we suggest it may be possible in the future
to deplete translational machinery from the protein sample to
increase the depth of analysis. Since proteomic analysis by iTRAQ
or 2-DE requires known protein sequences, the recent explosion of
deep sequencingmayquickly increase power of shotgunproteomic
analysis, which may assist in the determination of the functions of
many PUFs in organisms such as P. aeruginosa.
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